ADVERTISEMENT
Videos
Reduction of First Heart Attack, Stroke in Patients With Use of Recently Approved Drug
07/10/2020
Deepak L. Bhatt MD, MPH, FACC, FAHA, FSCAI, FESC, executive director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital Heart & Vascular Center and professor of Medicine at Harvard Medical School, discusses the benefits of Brilinta for reducing a first heart attack or stroke in patients with coronary artery disease.
